Posted in | News | Gold | Mining Business

Shamika2Gold Executes Exchange Agreement to Buy Gold and Ruby Exploration Licenses In Cambodia

Aultra Gold, Inc. (OTC BB: AGDI), operating internationally as Shamika2Gold, has executed a definitive securities exchange agreement to acquire a concession of a gold and ruby exploration license in Cambodia.

The area covered in the license is comprised of approximately 158 square miles in the Samlaut district adjacent to the famous Pailin ruby gem area. A Phase 1 & 2 Survey Report on the project was prepared by Terra Insight Services, Inc., a subsidiary of Terra Energy & Resource Technologies, Inc. (TEGR.OB), suggesting potential resources of 1.5 million ounces of gold and 9,000 kilograms of rubies.

“This is a very important acquisition for Shamika and confirms the company's strategy to acquire and develop international gold assets ready or close to production”

Upon consummation of the exchange, Shamika will acquire approximately 85% of the capital stock from the Mauritius holding company which, upon formation and contribution, will hold these mining rights in exchange for 57,000,000 shares of Shamika common stock and shares of Series B Performing Preferred Stock, entitling the holder to 45% of the net operating profit from the mining project. The closing is conditioned upon the formation of the holding company and subsequent contribution of the mining rights.

"This is a very important acquisition for Shamika and confirms the company's strategy to acquire and develop international gold assets ready or close to production," stated Robert Vivian, President and Chief Executive Officer.

Source:

Aultra Gold, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.